ALK Positive Lung Cancer UK
@alkpositiveuk.bsky.social
💙 Supporting, empowering & advocating for those with ALK+ lung cancer in the UK
🧬 Advocacy | Awareness | Trusted resources
🫶 NICE-recognised, improving lives, driving change, and amplifying our community voices
linktr.ee/alkpositivelungcanceruk
🧬 Advocacy | Awareness | Trusted resources
🫶 NICE-recognised, improving lives, driving change, and amplifying our community voices
linktr.ee/alkpositivelungcanceruk
Becca, who has stage 4 ALK+ #lungcancer, spoke on BBC Morning Live ahead of Lung Cancer Awareness Month 💙
Diagnosed nearly six years ago after back pain and vision problems, she’s helping challenge outdated ideas about who can get lung cancer.
#LungCancerAwarenessMonth #ALKPositive #LCSM
Diagnosed nearly six years ago after back pain and vision problems, she’s helping challenge outdated ideas about who can get lung cancer.
#LungCancerAwarenessMonth #ALKPositive #LCSM
October 31, 2025 at 8:35 AM
Becca, who has stage 4 ALK+ #lungcancer, spoke on BBC Morning Live ahead of Lung Cancer Awareness Month 💙
Diagnosed nearly six years ago after back pain and vision problems, she’s helping challenge outdated ideas about who can get lung cancer.
#LungCancerAwarenessMonth #ALKPositive #LCSM
Diagnosed nearly six years ago after back pain and vision problems, she’s helping challenge outdated ideas about who can get lung cancer.
#LungCancerAwarenessMonth #ALKPositive #LCSM
Prof Sanjay Popat shares why he’s feeling so optimistic about the future of ALK+ #lungcancer treatment.
With new targeted therapies, ADCs, & entirely new drug classes like PROTACs & molecular glues in development - alongside a growing understanding of ALK biology - the field is moving fast.
#LCSM
With new targeted therapies, ADCs, & entirely new drug classes like PROTACs & molecular glues in development - alongside a growing understanding of ALK biology - the field is moving fast.
#LCSM
October 25, 2025 at 8:19 AM
Prof Sanjay Popat shares why he’s feeling so optimistic about the future of ALK+ #lungcancer treatment.
With new targeted therapies, ADCs, & entirely new drug classes like PROTACs & molecular glues in development - alongside a growing understanding of ALK biology - the field is moving fast.
#LCSM
With new targeted therapies, ADCs, & entirely new drug classes like PROTACs & molecular glues in development - alongside a growing understanding of ALK biology - the field is moving fast.
#LCSM